Successful endoscopic sphincterotomy for choledocholithiasis in a patient with severe hemophilia A and inhibitors
- 122 Downloads
Endoscopic sphincterotomy (ES) is a standard procedure for bile duct stone removal. However, the safety of ES in patients with hemophilia remains unknown. We treated a 46-year-old man who had choledocholithiasis and severe hemophilia A with high-responding inhibitors during immune tolerance induction therapy. Since coagulation factor VIII inhibitors neutralize and inactivate endogenous and exogenous factor VIII, bleeding risk is higher in hemophilia A patients with inhibitors than in those without inhibitors. With adequate pre- and post-procedure monitoring of the clotting factor and supplemented clotting factor, the patient could safely undergo ES without bleeding complications. ES can be also an effective and safe first-line therapy for choledocholithiasis in patients with hemophilia and inhibitors under the condition of appropriate management.
KeywordsEndoscopic sphincterotomy Hemophilia Choledocholithiasis
Compliance with ethical standards
Conflict of interest
Drs. Sugiura, Kuwatani, Kawakubo, Sano, Kato, Endo and Sakamoto declare that they have no conflict of interest.
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent was obtained from the patient for being included in the study.
- 8.Kasper CK. Diagnosis and management of inhibitors to factor VIII and IX. World Fed Hemoph. 2004;1:22Google Scholar
- 15.White GC, Rosendaal F, Aledort LM, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2002;85(3):560 (Epub 2001/04/20).Google Scholar